Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025)
Cyclerion Therapeutics (CYCN) recorded quarterly Return on Assets of 0.0% in Q4 2025, up 3.01% quarter-over-quarter from 0.0% in Q3 2025.
Cyclerion Therapeutics (CYCN) Return on Assets (2019 - 2025) Analysis & Trends
Cyclerion Therapeutics' Return on Assets history runs 7 years deep, the most recent figure standing at 0.0% for Q4 2025.
- In Q4 2025, Return on Assets changed N/A year-over-year to 0.0%; the TTM figure through Dec 2025 stood at 0.0% (changed N/A YoY), while the FY2023 annual figure was 0.0%, up 1.0% from the prior year.
- Return on Assets was 0.0% for Q4 2025 at Cyclerion Therapeutics, up from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.01% in Q2 2024 to a low of 0.02% in Q1 2023.
- Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2021.
- The sharpest annual moves came in 2024 and 2025: Return on Assets increased 3 bps in 2024, then fell 2 bps in 2025.
- A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then slumped by 89 bps to 0.02% in 2022, then jumped by 131 bps to 0.01% in 2023, then jumped by 145 bps to 0.01% in 2024, then slumped by 132 bps to 0.0% in 2025.
- The last three Return on Assets figures came in at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -0.80% |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -0.01% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -0.01% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 0.00% |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 0.00% |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -0.01% |
| 10 | Cyclerion Therapeutics | 11.50 Mn | 8.26 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.01% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.02% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |
| Jun 30, 2021 | -0.01% |
| Mar 31, 2021 | -0.01% |
| Dec 31, 2020 | -0.01% |
| Sep 30, 2020 | -0.01% |